AURO PHARMA INC, — Escitalopram Importer Profile
Pharmaceutical Importer · #17 buyer for Escitalopram · $760.0K import value · 19 shipments · CANADA · DGFT Verified
AURO PHARMA INC, is the #17 importer of Escitalopram from India with $760.0K in import value and 19 verified shipments. AURO PHARMA INC, holds a 0.5% market share in Escitalopram imports based in CANADA. The company sources from 1 verified supplier across 14 formulations shipped to 1 country. Overall, AURO PHARMA INC, imports 11 pharmaceutical products worth $8.9M across 4 therapeutic categories.
AURO PHARMA INC, — Escitalopram Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Escitalopram to AURO PHARMA INC,?
Verified from 19 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LIMITED | $760.0K | 19 | 100.0% |
AURO PHARMA INC, sources Escitalopram from 1 verified Indian supplier based on 19 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.
Where Does AURO PHARMA INC, Import Escitalopram To?
Destination countries from 19 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $760.0K | 19 | 100.0% |
AURO PHARMA INC, imports Escitalopram to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $760.0K.
What Escitalopram Formulations Does AURO PHARMA INC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| ESCITALOPRAM 20 MG TABLETS (AURO-ESCITALOPRAM 20) 100'S (ESCITALOPRAM OXALATE TABS)(33408 PACK) | $145.7K | 3 |
| ESCITALOPRAM 10 MG TABLETS (AURO-ESCITALOPRAM 10) 100'S (ESCITALOPRAM OXALATE TABS)(25008 PACK) | $89.7K | 3 |
| ESCITALOPRAM 10 MG TABLETS(AURO-ESCITALOPRAM 10)100'S(QTY:33696PAK) | $71.7K | 2 |
| ESCITALOPRAM TABLETS USP 10MG (AURO-ESCI | $50.0K | 1 |
| ESCITALOPRAM 20 MG TABLETS(AURO-ESCITALO | $50.0K | 1 |
| ESCITALOPRAM 20 MG TABLETS (Auro-Escital | $50.0K | 1 |
| ESCITALOPRAM 10 MG TABLETS (AURO-ESCITALOPRAM 10) 100'S (QTY: 32760 PAK) | $50.0K | 1 |
| ESCITALOPRAM 20 MG TABLETS(AURO-ESCITALOPRAM 20)100'S(QTY:25344PAK) | $50.0K | 1 |
| ESCITALOPRAM 20 MG TABLETS (AURO-ESCITALOPRAM 20) 100'S (QTY: 12477 PAK) | $50.0K | 1 |
| ESCITALOPRAM 20 MG TABLETS(AURO-ESCITALOPRAM 20)100'S(QTY:32880PAK) | $50.0K | 1 |
AURO PHARMA INC, imports 14 distinct Escitalopram formulations from India. The top formulation is ESCITALOPRAM 20 MG TABLETS (AURO-ESCITALOPRAM 20) 100'S (ESC with 3 shipments worth $145.7K.
Regulatory Requirements: Importing Escitalopram into Canada
What AURO PHARMA INC, and other importers must comply with to import Escitalopram from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Escitalopram
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Escitalopram from India and How Much Does AURO PHARMA INC, Import?
India exported $33.3M worth of Escitalopram through 5,457 shipments from 231 suppliers to 95 countries, serving 628 buyers globally. AURO PHARMA INC, imports $760.0K of this total, accounting for 0.5% of India's Escitalopram exports with 19 shipments from CANADA. This is verified from 19 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for AURO PHARMA INC,'s Escitalopram Imports?
AURO PHARMA INC,'s average Escitalopram order value is $40.0K per consignment, based on 19 shipments totaling $760.0K. AURO PHARMA INC, is based in CANADA and ranks #17 among all Escitalopram importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Escitalopram to AURO PHARMA INC,?
AURO PHARMA INC, sources Escitalopram from 1 verified Indian supplier: AUROBINDO PHARMA LIMITED ($760.0K, 100.0%). This is based on 19 customs records.
How Does AURO PHARMA INC, Compare to Other Escitalopram Importers?
AURO PHARMA INC, ranks #17 among 628 Escitalopram importers from India with a 0.5% market share. The top 3 importers are TORRENT PHARMA INC ($4.2M), LEK S.A. ($4.1M), CIPLA MAROC ($3.5M). AURO PHARMA INC, processed 19 shipments from CANADA.
What Other CNS & Psychiatric Products Does AURO PHARMA INC, Import?
AURO PHARMA INC, also imports these cns & psychiatric products. Each links to the detailed product page.
About AURO PHARMA INC,
AURO PHARMA INC, imports 11 products worth $8.9M. Beyond Escitalopram, top products include Sertraline, Cefixime, Dapagliflozin, Ertapenem, Repaglinide. View the complete AURO PHARMA INC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Escitalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Escitalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AURO PHARMA INC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AURO PHARMA INC,'s capped import value divided by total capped export value for Escitalopram across all Indian exporters.
- 5.Verified Records: This page is backed by 19 individual customs records matching AURO PHARMA INC, importing Escitalopram, covering 14 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 95+ countries, 628+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Escitalopram Import Data for AURO PHARMA INC,
Access order-level details, pricing data, supplier connections, and competitive analysis for AURO PHARMA INC,'s Escitalopram imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AURO PHARMA INC,
Full Company Profile →
11 products · $8.9M total trade · 4 categories
AURO PHARMA INC, × Escitalopram
Verified from customs records
Company Overview
Top Products by AURO PHARMA INC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AURO PHARMA INC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Escitalopram. For current order-level data, contact TransData Nexus.